Vericel (VCEL) Short-term Investments (2018 - 2026)
Vericel's (VCEL) quarterly Short-term Investments came in at $36.0 million in Q1 2026, up 479.97% year-on-year from $6.2 million in Q1 2025, and down 3.64% quarter-over-quarter from $37.4 million in Q4 2025.
Vericel (VCEL) Short-term Investments (2018 - 2026) Analysis & Trends
Vericel has disclosed Short-term Investments across 9 years of filings, most recently posting $36.0 million for Q1 2026.
- Short-term Investments for Q1 2026 came in at $36.0 million, up 479.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.0 million (up 479.97% YoY), and the FY2025 annual result was $37.4 million, down 10.28% from the prior year.
- Short-term Investments came in at $36.0 million for Q1 2026 at Vericel, down from $37.4 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $57.4 million in Q1 2023 to a low of $6.2 million in Q1 2025.
- The 5-year median for Short-term Investments is $41.7 million (2024), against an average of $37.4 million.
- Across the five-year window, Short-term Investments slumped 86.97% in 2025 and soared 479.97% in 2026, its largest moves.
- Vericel's Short-term Investments stood at $45.7 million in 2022, then tumbled by 61.12% to $17.8 million in 2023, then jumped by 134.52% to $41.7 million in 2024, then decreased by 10.28% to $37.4 million in 2025, then retreated by 3.64% to $36.0 million in 2026.
- The last three Short-term Investments figures came in at $36.0 million (Q1 2026), $37.4 million (Q4 2025), and $35.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.05 Mn |
| Dec 31, 2025 | 37.41 Mn |
| Sep 30, 2025 | 34.98 Mn |
| Mar 31, 2025 | 6.22 Mn |
| Dec 31, 2024 | 41.69 Mn |
| Sep 30, 2024 | 16.67 Mn |
| Jun 30, 2024 | 52.22 Mn |
| Mar 31, 2024 | 47.71 Mn |
| Dec 31, 2023 | 17.78 Mn |
| Sep 30, 2023 | 23.09 Mn |
| Jun 30, 2023 | 54.81 Mn |
| Mar 31, 2023 | 57.44 Mn |
| Sep 30, 2022 | 45.72 Mn |
| Jun 30, 2022 | 44.64 Mn |
| Mar 31, 2022 | 44.89 Mn |
| Dec 31, 2021 | 35.07 Mn |
| Sep 30, 2021 | 43.74 Mn |
| Jun 30, 2021 | 39.21 Mn |
| Mar 31, 2021 | 25.40 Mn |
| Dec 31, 2020 | 42.19 Mn |